The positive airway pressure devices market has seen considerable growth due to a variety of factors.
• The market size for positive airway pressure devices has seen a swift expansion in the past few years. The market is expected to rise from a valuation of $4.26 billion in 2024 to $4.69 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.1%.
The significant growth observed during the historical period can be credited to the rising demand for sleep apnea and respiratory therapy, increase in aging population and chronic diseases, the broadening of home healthcare solutions, incorporation in neonatal and pediatric care, and adherence to regulatory standards for medical devices.
The positive airway pressure devices market is expected to maintain its strong growth trajectory in upcoming years.
• Anticipations are high for the positive airway pressure devices market, with accelerated growth projected over the next few years. The market is projected to expand to an estimated $7.51 billion by the year 2029, making it a compound annual growth rate of 12.5%.
The surge in the market during the forecast period can majorly be linked to the advent of patient-focused and personalized airway pressure tools, advancements in telemedicine and remote health monitoring, tailor-made devices for specific respiratory ailments, the broadening scope of telehealth and virtual sleep clinics, as well as a surge in usage within sports and performance sleep. Significant trends expected during the forecast period encircle the application of artificial intelligence and machine learning in managing sleep disorders, maintaining regulatory compliance in ensuring airway pressure device safety, portable and traveler-friendly positive airway pressure (PAP) solutions, devices specifically designed for pediatric and infant use, and wearable PAP technology for constant monitoring.
It is projected that the escalating elderly population will fuel the expansion of the positive airway pressure (PAP) devices market in the upcoming years. It's observed that elderly people are more susceptible to sleep apnea conditions. The elevated occurrence of obstructive sleep apnea (OSA) is associated with the reduction in the size of the upper airway lumen due to aging. For example, in January 2022, the Congressional Budget Office, an American federal body, anticipated that the population eligible for Social Security payroll taxes and benefits will climb from 342 million in 2024 to 383 million by 2054. This surge is propelled by substantial growth in the age group of 65 and older, leading to a generally aging population. Therefore, the burgeoning elderly population is more likely to be affected by apnea, which is expected to stimulate the market.
The positive airway pressure devices market covered in this report is segmented –
1) Product Type: Continuous Positive Airway Pressure (CPAP), Auto-titrating Positive Airway Pressure (APAP), BiLevel Positive Airway Pressure (BiPAP)
2) By Application: Sleep Apnea, COPD, Other Applications
3) By End-user: Hospitals & Sleep Labs, Home Care Settings, Other End-users
Subsegments:
1) By Continuous Positive Airway Pressure (CPAP): Fixed CPAP Devices, CPAP With Humidifier, CPAP With Integrated Monitors
2) By Auto-titrating Positive Airway Pressure (APAP): APAP With Humidifier, APAP With Integrated Monitors, Smart APAP Devices
3) By BiLevel Positive Airway Pressure (BiPAP): BiPAP With BiFlex Technology, BiPAP With Humidifier, BiPAP With Integrated Monitors
In the Positive Airway Pressure Devices market, major industry players are prioritizing the development of technologically advanced solutions such as Bi-level sleep apnea devices. This strategy aims to improve patient comfort, compliance, and treatment outcomes. Bi-level sleep apnea devices, considered a more developed form of Positive Airway Pressure (PAP) machines, deliver two different levels of air pressure to the patient during sleep. They supply a higher pressure during inhalation and a lower one while exhaling, thus enabling those with sleep apnea to breathe comfortably all night. For example, in February 2024, ResMed, an American medical device firm, introduced a new bi-level sleep apnea device, the AirCurve 11, as a substitute for traditional CPAP therapy. The AirCurve 11 improves treatment for sleep apnea by providing customized dual pressure settings which enhance comfort and compliance. Its built-in digital health features give users the ability to monitor progress and receive individualized coaching, making treatment more efficient and user-friendly.
Major companies operating in the positive airway pressure devices market include:
• ResMed Corporation
• Royal Philips N.V.
• 3B Medical Corporation
• Fisher & Paykel Healthcare Corporation Limited
• Drive DeVilbiss Healthcare Inc.
• Somnetics International Corporation
• Heyer-Schulte Medical Corp.
• BMC Medical Inc.
• Apex Medical Corporation
• Armstrong Medical Industries Inc.
• Curative Medical Corporation
• Compumedics Corporation Limited
• CareFusion Corporation
• Mercury Medical Inc.
• Khayat Medical Industries S.A.R.L
• Vyaire Medical Inc.
• Teijin Limited
• Medtronic plc
• Servona AG
• Medical Depot Corporation
• Weinmann Emergency Medical Technology GmbH & Co. KG
• Beijing Dehaier Medical Technology Co. Ltd.
• Breas Medical AB
• General Electric Healthcare
• Hamilton Medical AG
• Invacare Corporation
• Medline Industries Inc.
• Nihon Kohden Corporation
• Oventus Medical Limited
• SomnoMed Limited
North America was the largest region in the positive airway pressure devices market in 2024. Asia-Pacific is predicted to record the fastest growth over the forecast period. The regions covered in the positive airway pressure devices market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.